DR. WELLINGTON SUN, M.D.
Osteopathic Medicine at Rockville Pike, Rockville, MD

License number
Maryland MD30995
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address 2
1401 Rockville Pike SUITE 300N, Rockville, MD 20852
4400 Woodfield Rd, Kensington, MD 20895
Phone
(301) 827-3070
(301) 827-3532 (Fax)
(301) 530-7872

Personal information

See more information about WELLINGTON SUN at radaris.com
Name
Address
Phone
Wellington Sun, age 68
4400 Woodfield Rd, Kensington, MD 20895
(301) 530-7872
Wellington Sun
Rockville, MD
(301) 530-7872
Wellington Sun, age 68
10105 Daphney House Way, Rockville, MD 20850
(301) 294-3399

Organization information

See more information about WELLINGTON SUN at bizstanding.com

Wellington Sun MD

1401 Rockville Pike RM 300N, Rockville, MD 20852

Industry:
Internist
Phone:
(301) 796-2640 (Phone), (301) 827-3070 (Phone)
Wellington Sun
Categories:
Infectious Disease Physicians & Surgeons

Professional information

Wellington Sun Photo 1

Dr. Wellington Sun, Rockville MD - MD (Doctor of Medicine)

Specialties:
Infectious Disease Medicine
Address:
1401 Rockville Pike SUITE 300N, Rockville 20852
(301) 827-3070 (Phone), (301) 827-3532 (Fax)
HFM-475
1401 Rockville Pike SUITE 370, Rockville 20852
(301) 827-3070 (Phone), (304) 263-8063 (Fax)
Certifications:
Infectious Disease, 2005, Internal Medicine, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Uniformed Services University of The Health Sciences
Graduated: 1983
William Beaumont Army Medical Center
Walter Reed Army Medical Center


Wellington Sun Photo 2

Multivalent Dengue Virus Vaccine

US Patent:
2007008, Apr 19, 2007
Filed:
Jul 24, 2003
Appl. No.:
10/626315
Inventors:
Kenneth Eckels - Rockville MD, US
Joseph Putnak - Silver Spring MD, US
Doria Dubois - Wheaton MD, US
Bruce Innis - Haverford PA, US
Charles Hoke - Columbia MD, US
Wellington Sun - Rockville MD, US
Niranjan Kanesa-Thasan - Rockville MD, US
International Classification:
A61K 39/395, A61K 39/12
US Classification:
424204100, 424130100
Abstract:
The present invention provides vaccine compositions of attenuated dengue virus. More specifically, the attenuated virus is produced by serial passage in PDK cells. The invention also provides methods for stimulating the immune system of an individual to induce protection against all four dengue virus serotypes by administration of attenuated dengue-1, dengue-2, dengue-3, and dengue-4 virus.